{
    "SPADE_N_00057": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_00057",
            "Peptide Name": "Garvieacin Q (GarQ; Bacteriocin)",
            "Source": "Lactococcus garvieae BCC 43578 (Gram-positive bacteria)",
            "Family": "Belongs to the class II bacteriocin",
            "Gene": "Not found",
            "Sequence": "EYHLMNGANGYLTRVNGKTVYRVTKDPVSAVFGVISNCWGSAGAGFGPQH",
            "Sequence Length": 50,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+"
            ],
            "Target Organism": "Gram-positive bacteria:Bacillus coagulans JCM 2257, Listeria monocytogenes ATCC 19115, L. garvieae strains, E. faecium D48S52, Lactobacillus plantarum BCC 9546, Lactobacillus sakeii JCM 1157, L. ivanovii DMST 9012 (MIC=0.1-1.6 uM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.22210221] Purified GarQ, up to 1 mg/mL, was not cytotoxic to Vero (African green monkey kidney), HepG (human liver hepatocarcinoma) and Caco-2 (human colon adenocarcinoma) cell lines. Vero, HepG2 and Caco-2 have 94 ± 8, 97 ± 4 and 89 ± 7 % survival with indicated concentration (1mg/mL) of purified garvieacin Q compared to that of untreated control using the MTT assay.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C237H358N68O69S2",
            "Mass": 5327.92,
            "PI": 9.06,
            "Net Charge": 4,
            "Hydrophobicity": -0.18,
            "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour",
            "Comments": "No comments found on DRAMP database",
            "Literature": [
                {
                    "Title": "Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578.",
                    "Pubmed ID": "22210221",
                    "Reference": "Appl Environ Microbiol. 2012 Mar;78(5)1619-1623.",
                    "Author": "Tosukhowong A, Zendo T, Visessanguan W, Roytrakul S, Pumpuang L, Jaresitthikunchai J, Sonomoto K.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22210221"
                }
            ],
            "Frequent Amino Acids": "GVA",
            "Absent Amino Acids": "OU",
            "Basic Residues": 6,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 22,
            "Polar Residues": 31,
            "Positive Residues": 6,
            "Negative Residues": 2,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15822",
                    "Similarity": 0.96,
                    "Sequence": "EYHLMNGANGYLTRVNGKYVYRVTKDPVSAVFGVISNGWGSAGAGFGPQH"
                }
            ]
        }
    }
}